Home About ICON Company history Company history From a small team of 5 people in 1990, ICON now employs over 41,100 people We have mainly grown organically, but have bolstered our growth...
ICON is led by an experienced leadership team with deep expertise across the life sciences industry. Dr. Steve Cutler ; Mr. Nigel Clerkin ; Dr. Ute Berger ; Mr. Barry Balfe ; Dr. Chris Smyth ; Dr. Greg Licholai ; Ms. Laurie Dohmeyer ; Ms. Rose Kidd ; Mr. Diarmaid Cunningham ; Mr. Tom O'Leary
ICON IGP is the federal business unit of ICON plc, a top three global Contract Research Organisation (CRO) with over 41,000 employees across 53 countries. Our award-winning study execution capabilities and teams have led to the approval of 18 of the world’s top 20 best-selling drugs. As part of ICON we have the extended reach and resources to support government and non-governmental clients alike, and to carry out our mission of addressing global health concerns. We have over 25 years’ experience in directly supporting multiple government ag ...
Bioanalytical Laboratories · The highest quality services for pharmacokinetic, immunogenicity, and biomarker analysis, utilising a wide range of platforms for small molecules, large molecules, and cell-based entities. Central Laboratories · A full range of central laboratory services dedicated to the delivery of high quality, harmonised data from a global laboratory network. Specialty Laboratories · Streamlining the co-development of flexible, platform-agnostic molecular diagnostic tests t...
ICON works with sponsors to: ; Develop and/or optimise flow cytometry methodology to meet the required specifications for monitoring therapeutics ; Provide the sponsor with validation data and work in a collaborative manner during the assay development/validation stage ; Roll out flow cytometric assays globally as required
Digital Health Technologies · Integrated end-to-end approach incorporating digital endpoints, trial design, execution and reporting. ; In-Home Services · Patient assessments in-home or at an alternative convenient site to reduce patient burden and increase patient engagement. ; Concierge Services · Connecting with the patient for a more positive experience
Technology solutions from early phase through to post-marketing. ; ICON provides its full range of clinical, consulting and commercial services across several industry sectors. ; A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment. ; An evolving understanding of cancer biology has resulted in the rise of precision-informed treatment approaches.
Technology solutions from early phase through to post-marketing. ; ICON provides its full range of clinical, consulting and commercial services across several industry sectors. ; A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment. ; An evolving understanding of cancer biology has resulted in the rise of precision-informed treatment approaches.
Keep up with the latest security insights for 1inch Network: Audits Security Scores, KYC, Honors, On-Chain Monitoring, Bug Bounty and more.
ICON’s clinics are managed, staffed, and supported by industry-leading experts who have the scientific knowledge and experience to successfully deliver even the most complex of studies. We operate state-of-the-art facilities in the Netherlands and North America, as well as an innovative patient pharmacology model in Central and Eastern Europe. Laboratory facilities are situated close to the clinics and configured to support all study requirements. Each clinic has a dedicated healthy volunteer ...